about
Is adiposopathy (sick fat) an endocrine disease?The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveysCurrent and investigational antiobesity agents and obesity therapeutic treatment targets.Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.Insulin sensitisation in the treatment of Type 2 diabetes.Pharmacotherapy for dyslipidaemia--current therapies and future agents.Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence.Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.Risk of completed suicide after bariatric surgery: a systematic review.Morinda citrifolia L. leaf extract prevent weight gain in Sprague-Dawley rats fed a high fat diet.Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.Simple Analysis of Lipid Inhibition Activity on an Adipocyte Micro-Cell Pattern Chip.Adiposopathy: why do adiposity and obesity cause metabolic disease?
P2860
Q24655610-AFD9D101-E2B3-42A2-BE48-B165CC76C6F8Q31112204-111A0380-8100-4C28-97DD-138ECF83FF75Q34344786-0FDC7D4A-D589-4FAA-A6B4-074E4A7E888FQ34659424-BC9D71E3-CC4C-441A-A1D8-EBD29E17C503Q35073317-A6FF670A-F826-4B92-A8A9-F7C99BC3989DQ35574960-026B7F0E-28EF-4D77-A325-11BF09DBACE2Q36804810-FE361B1D-147A-47BD-8276-4DA2BF8ACD9BQ37626059-FFCBDE39-66E1-435D-88CC-6B27303ED5D1Q38072445-0675E653-E3AD-4DEF-ABC2-48F1D9CA2E89Q41356737-A83723E4-B196-4C9E-AB2B-6894D735E726Q43138240-5D0D4D47-8C51-4034-B727-E7E5EB4F08E5Q55397784-D6DE0FD2-32A7-4CA3-AB34-FCB11B041F7FQ56567724-0C230DB3-C29A-4EB1-9B8F-F5940E76439E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anti-obesity drug development.
@ast
Anti-obesity drug development.
@en
Anti-obesity drug development.
@nl
type
label
Anti-obesity drug development.
@ast
Anti-obesity drug development.
@en
Anti-obesity drug development.
@nl
prefLabel
Anti-obesity drug development.
@ast
Anti-obesity drug development.
@en
Anti-obesity drug development.
@nl
P2860
P1476
Anti-obesity drug development.
@en
P2093
Carlos Dujovne
Harold Bays
P2860
P304
P356
10.1517/13543784.11.9.1189
P407
P577
2002-09-01T00:00:00Z